NADPH oxidase 4 is an oncoprotein localized to mitochondria

Area of Science:

• Biochemistry
• Cell Biology
• Oncology

Background:

• Reactive oxygen species (ROS) play critical roles in cellular functions and disease.
• NADPH oxidase (NOX) proteins, initially identified in phagocytes, are now known to be expressed in various tissues.
• NOX family members exhibit diverse tissue-specific expression and functions.

Purpose of the Study:

• To investigate the expression and role of NOX family proteins (NOX1-5) in normal breast tissue and breast tumors.
• To determine the specific contribution of NOX4 to breast cancer development and progression.
• To explore the potential of targeting NOX4 for cancer therapy.

Main Methods:

• Gene expression analysis of NOX1-5 in normal breast tissues, breast cancer cell lines, and primary tumors.
• Cellular assays to assess the impact of NOX4 overexpression on senescence, apoptosis resistance, and tumorigenicity.
• Mitochondrial localization studies of NOX4 using a green fluorescent protein (GFP) reporter.
• Evaluation of antioxidant treatment (catalase) on NOX4-overexpressing cells.

Main Results:

• Normal breast tissues express NOX1, NOX4, and NOX5 genes.
• NOX4 is significantly overexpressed in most breast cancer cell lines, primary breast tumors, and ovarian tumors.
• Overexpression of NOX4 induces cellular senescence, apoptosis resistance, and tumorigenic transformation in normal breast epithelial cells.
• NOX4 overexpression enhances tumorigenicity in already transformed breast tumor cells.
• NOX4 localizes to mitochondria via an N-terminal signal sequence, generating mitochondrial ROS.
• Catalase treatment reduces the tumorigenic characteristics of NOX4-overexpressing cells.

Conclusions:

• NOX4 exhibits an oncogenic function, particularly when localized to mitochondria.
• NOX4 is a novel source of mitochondrial ROS implicated in breast cancer.
• Targeting NOX4 with antioxidants presents a potential therapeutic avenue for NOX4-driven breast cancers.